| scholarly article | Q13442814 |
| P50 | author | Patricia C Grenzi | Q59592232 |
| Jose Osmar Medina Pestana | Q59698523 | ||
| P2093 | author name string | Marcello F Franco | |
| Maria Gerbase-Delima | |||
| Hélio Tedesco-Silva | |||
| Maria Fernanda Soares | |||
| Claudia R Felipe | |||
| Érika F Campos | |||
| P2860 | cites work | Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens | Q33246671 |
| Advances in pre- and posttransplant immunologic testing in kidney transplantation | Q35687821 | ||
| Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection | Q37654098 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses | Q40712496 | ||
| Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | Q43580802 | ||
| Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1year post-transplantation | Q44215754 | ||
| Posttransplant sCD30 as a predictor of kidney graft outcome | Q44999142 | ||
| Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts | Q45287212 | ||
| CD30 expression identifies a functional alloreactive human T-lymphocyte subset. | Q45957936 | ||
| Association between serum soluble CD30 and serum creatinine before and after renal transplantation. | Q46246128 | ||
| Soluble CD30 correlates with clinical but not subclinical renal allograft rejection | Q46270370 | ||
| Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy | Q47588333 | ||
| Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. | Q51060341 | ||
| Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure. | Q51789761 | ||
| Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory. | Q51993471 | ||
| Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. | Q53243295 | ||
| Transplant glomerulopathy: subclinical incidence and association with alloantibody. | Q53543179 | ||
| Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells | Q59090441 | ||
| The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
| Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1 | Q73276645 | ||
| CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme | Q73306726 | ||
| Soluble CD30 as a predictor of kidney graft outcome | Q77493923 | ||
| CD30: expression and function in health and disease | Q77593448 | ||
| Infiltrates in protocol biopsies from renal allografts | Q79731728 | ||
| Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates | Q79741123 | ||
| Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') | Q79921621 | ||
| Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival | Q80054535 | ||
| Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection | Q81813237 | ||
| Panel reactive HLA antibodies, soluble CD30 levels, and acute rejection six months following renal transplant | Q82389220 | ||
| Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation | Q83206971 | ||
| Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts | Q84139761 | ||
| P433 | issue | 1-4 | |
| P304 | page(s) | 34-38 | |
| P577 | publication date | 2013-08-06 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy | |
| P478 | volume | 29 |
| Q38445336 | Achieving incompatible transplantation through desensitization: current perspectives and future directions |
| Q36718807 | BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients |
| Q36285580 | Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review. |
| Q38703426 | Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study |
| Q38793766 | Immune monitoring in renal transplantation: The search for biomarkers |
| Q86779666 | Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation |
Search more.